The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma

被引:1
|
作者
Ning, Zhong-Hua [1 ,2 ]
Zhao, Wei [3 ]
Li, Xiao-Dong [1 ]
Chen, Lu-Jun [1 ]
Xu, Bin [1 ]
Gu, Wen-Dong [2 ]
Shao, Ying-Jie [2 ]
Xu, Yun [1 ]
Huang, Jin [2 ]
Pei, Hong-Lei [2 ]
Jiang, Jing-Ting [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou 213003, Peoples R China
[2] Soochow Univ, Affiliated Hosp 3, Dept Radiat Oncol, Changzhou 213003, Peoples R China
[3] Soochow Univ, Affiliated Hosp 3, Dept Pathol, Changzhou 213003, Peoples R China
基金
中国国家自然科学基金;
关键词
Biomarkers; perineural invasion; prognosis; esophageal squamous cell carcinoma; postoperative radiotherapy; PROSTATE-CANCER; NEURAL INVASION; CURATIVE RESECTION; PANCREATIC-CANCER; RADIATION-THERAPY; SURVIVAL; ADJUVANT; CHEMORADIOTHERAPY; NEOADJUVANT; STROMA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Prognosis of locally advanced esophageal squamous cell carcinoma (ESCC) remains dismal even after curative resection and adjuvant radiotherapy. New biomarkers for predicting prognosis and treatment outcomes are needed for improved treatment stratification of patients with locally advanced ESCC. The prognostic and treatment predictive significance of perineural invasion (PNI) in the locally advanced ESCC remains unclear. This study aimed to examine the effect of PNI on the outcomes of locally advanced ESCC patients after curative resection with or without postoperative radiotherapy (PORT). Patients and methods: We retrospectively reviewed 262 consecutive locally advanced ESCC patients who underwent curative resection. Tumors sections were re-evaluated for PNI by an independent pathologist blinded to the patients' outcomes. Overall survival (OS) and disease-free survival (DFS) were determined using the Kaplan-Meier method; univariate log-rank test and multivariate Cox proportional hazard model were used to evaluate the prognostic value of PNI. Results: Finally, 243 patients were analyzed and enrolled into this study, of which 132 received PORT. PNI was identified in 22.2% (54/243) of the pathologic sections. The 5-year DFS was favorable for PNI-negative patients versus PNI-positive patients (21.3% vs. 36.7%, respectively; P = 0.005). The 5-year OS was 40.3% for PNI-negative patients versus 21.7% for PNI-positive patients (P < 0.001). On multivariate analysis, PNI was an independent prognostic factor. In a subset analysis for patients received PORT, PNI was evaluated as a prognostic predictor as well (P < 0.05). In contrast to patients without PORT, PORT couldn't improve the disease recurrence and survival in locally advanced ESCC patients with PNI-positive (P > 0.05). Conclusions: PNI could serve as an independent prognostic factor and prognosticate treatment outcomes in locally advanced ESCC patients. The PNI status should be considered when stratifying high-risk locally advanced ESCC patients for adjuvant radiotherapy. Future prospective study is warranted to confirm our results.
引用
收藏
页码:6881 / 6890
页数:10
相关论文
共 50 条
  • [41] What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion?
    Han, Anne
    Ratner, Desiree
    CANCER, 2007, 109 (06) : 1053 - 1059
  • [42] Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma
    Wong, Lye-Yeng
    Liou, Douglas Z. Z.
    Vitzthum, Lucas K. K.
    Backhus, Leah M. M.
    Lui, Natalie S. S.
    Chang, Daniel
    Shrager, Joseph B. B.
    Berry, Mark F. F.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2212 - 2223
  • [43] Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma
    Lye-Yeng Wong
    Douglas Z. Liou
    Lucas K. Vitzthum
    Leah M. Backhus
    Natalie S. Lui
    Daniel Chang
    Joseph B. Shrager
    Mark F. Berry
    Annals of Surgical Oncology, 2023, 30 : 2212 - 2223
  • [44] Perioperative outcomes and survival after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma
    Yang, Xinyu
    Yin, Hao
    Zhang, Shaoyuan
    Jiang, Tian
    Gu, Jianmin
    Jiao, Heng
    Wang, Hao
    Liang, Fei
    Xu, Songtao
    Fan, Hong
    Ding, Jianyong
    Ge, Di
    Wang, Qun
    Yin, Jun
    Tan, Lijie
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2025, 169 (01):
  • [45] Survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma
    Lv, Huilai
    Zhang, Fan
    Huang, Chao
    Xu, Shi
    Li, Jiachen
    Sun, Bokang
    Gai, Chunyue
    Liu, Zhao
    Wang, Mingbo
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (05)
  • [46] The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
    Lo, Chien-Ming
    Wang, Yu-Ming
    Chen, Yen-Hao
    Fang, Fu-Min
    Huang, Shun-Chen
    Lu, Hung-, I
    Li, Shau-Hsuan
    CURRENT ONCOLOGY, 2021, 28 (02) : 1354 - 1365
  • [47] Predictive nomogram for postoperative atrial fibrillation in locally advanced esophageal squamous carcinoma cell with neoadjuvant treatment
    Fang, Meiqin
    Chen, Mingduan
    Du, Xiaoqiang
    Chen, Shuchen
    FRONTIERS IN SURGERY, 2023, 9
  • [48] Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy
    Kong, Yue
    Su, Miaoyi
    Fang, Jun
    Chen, Mengyuan
    Zheng, Chao
    Jiang, Youhua
    Tao, Kaiyi
    Wang, Changchun
    Qiu, Guoqin
    Ji, Yongling
    Wang, Yuezhen
    Yang, Yang
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [49] Upfront surgery and postoperative chemoradiation when needed strategy in locally advanced esophageal squamous cell carcinoma
    Hsu Po-Kuei
    Chen Hui-Shan
    Liu Chia-Chuan
    Wu Shiao-Chi
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] Radiotherapy for Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy Combined with Chemotherapy
    Kong, Y.
    Ji, Y.
    Qiu, G.
    Wang, Y.
    Fang, J.
    Chen, M.
    Chen, Q.
    Jiang, Y.
    Yang, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E309 - E310